Table 1.
Variables | Common clinical manifestations | Rehabilitation |
---|---|---|
Population characteristics | RSV-infected children aged five years and younger | |
Intervention or exposure | RSV infection in the first five years of life | |
Comparator (s) | a | RSV-negative children |
Outcomes | Common clinical manifestations | Wheezing illnessb |
Study design | Cohort study, cross-sectional study, case–control study, case-cohort study, and nested case–control study | Case–control study, case-cohort study, and cohort study |
Year published | January 1, 2010 to June 2, 2022 | |
Sample size | More than 100 | |
Exclusion | (1) Adults, the elderly, or children over the age of five; (2) unhealthy children, children with congenital heart disease or immunodeficiency disease, etc.; (3) reported composition ratio; (4) comparison of two RSV detection methods; (5) studies on languages other than Chinese and English; (6) animal research, repeated publications, letters, comments, case reports, case series, editorials, reviews, pure model studies, or model studies for trend estimation; (7) full text that was not available; and (8) only articles with the most comprehensive data were included in the repeated articles |
PICO population, intervention or exposure, comparators, and outcomes RSV respiratory syncytial virus
aTo calculate a single proportion of each clinical manifestation, and no comparator variables for this section
bBecause studies did not use consistent definitions for asthma and other wheezing illnesses, all variations of wheezing illness were combined into a single outcome